Skip to main content
Top

Drugs

Issue 8/2024

Content (11 Articles)

New and Evolving Treatments for Neurologic Dysphagia

Ayodele Sasegbon, Ivy Cheng, Bendix Labeit, Sriramya Lapa, Nathalie Rommel, Shaheen Hamdy

Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity

Luděk Horváth, Miloš Mráz, Edward B. Jude, Martin Haluzík

Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses

Zhiying Cao, Kaiyue Han, Hanting Lu, Sandalika Illangamudalige, Christina Abdel Shaheed, Lingxiao Chen, Andrew J. McLachlan, Asad E. Patanwala, Christopher G. Maher, Chung-Wei Christine Lin, Lyn March, Manuela L. Ferreira, Stephanie Mathieson

Mavorixafor: First Approval

  • Wart
  • AdisInsight Report

Sheridan M. Hoy

Zolbetuximab: First Approval

Susan J. Keam

Tovorafenib: First Approval

Sohita Dhillon

Tarlatamab: First Approval

  • SCLC
  • AdisInsight Report

Sohita Dhillon

Tunlametinib: First Approval

Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images